Researchers showed that sublethal doxorubicin treatment led to increased migration and invasion in otherwise non-invasive MCF7 breast cancer cells.
[Breast Cancer Research]
6445218
{6445218:EJFL2EGH}
apa
50
1
165142
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
